Overview
David Calfee is an Internal Medicine provider in New York, New York. Dr. Calfee is highly rated in 1 condition, according to our data. His top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Sepsis, Pneumonia, and Severe Acute Respiratory Syndrome (SARS).
His clinical research consists of co-authoring 94 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
1300 York Ave, New York, NY 10065
20 York St, New Haven, CT 06510
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Icahn School Of Medicine At Mount Sinai
Mark Lebwohl is an Internal Medicine provider in New York, New York. Dr. Lebwohl is highly rated in 34 conditions, according to our data. His top areas of expertise are Plaque Psoriasis, Psoriasis, Pustular Psoriasis, and Generalized Pustular Psoriasis (GPP).
CUIMC/Vivian & Seymour Milstein Family Heart Center
Mathew S. Maurer, MD - Dr. Maurer is a general internist and geriatric cardiologist with advanced training in heart failure and cardiac transplantation. He is the Arnold and Arlene Goldstein Professor of Cardiology at Columbia University Irving Medical Center, Vagelos College of Physicians & Surgeons, where directs the Clinical Cardiovascular Research Laboratory for the Elderly (CCRLE). Dr. Maurer is a member of the Advanced Cardiac Care Center at NewYork Presbyterian Hospital – Columbia Campus. He is the Director of the Cardiac Amyloidosis Program. He has published over 300 articles including peer reviewed manuscripts, reviews and book chapters. He was Chair of the American College of Cardiology’s Geriatric Cardiology Member Section, which is the largest organization dedicated to advancing the care of older adults with cardiovascular disease. He was co-chair of the Steering Committee of the ATTR-ACT trial showing tafamidis was a safe and effective therapy for transthyretin amyloid cardiomyopathy. Throughout his career, he has promulgated an approach to older adults with cardiovascular disease that offers the best of both geriatric and cardiovascular medicine in which a comprehensive holistic approach to enhance functional capacity and quality of life is at the forefront of emerging techniques to address cardiovascular physiologic derangement that disproportionately afflict older adults. Dr. Maurer is highly rated in 21 conditions, according to our data. His top areas of expertise are Cardiac Amyloidosis, Primary Amyloidosis, Transthyretin Amyloid Cardiomyopathy, Heart Transplant, and Transcatheter Aortic Valve Replacement (TAVR).
NewYork Presbyterian Columbia University Irving Medical Center
John Bilezikian is an Internal Medicine provider in New York, New York. Dr. Bilezikian is highly rated in 21 conditions, according to our data. His top areas of expertise are Hyperparathyroidism, Hypoparathyroidism, Hypercalcemia, Parathyroidectomy, and Hormone Replacement Therapy (HRT).
Frequently Asked Questions about Dr. David Calfee
How do I make an appointment with Dr. David Calfee?
You can book an appointment with Dr. David Calfee by calling their office at 646-962-4800. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. David Calfee a top-rated expert for Methicillin-Resistant Staphylococcus Aureus (MRSA)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. David Calfee is classified as an Distinguished expert for Methicillin-Resistant Staphylococcus Aureus (MRSA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. David Calfee specialize in?
While Dr. David Calfee is a Internal Medicine, they have specific expertise in Methicillin-Resistant Staphylococcus Aureus (MRSA), Sepsis, and Pneumonia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.
Does Dr. David Calfee participate in research or clinical trials?
Yes. Dr. David Calfee has published 94 articles and abstracts on conditions like Methicillin-Resistant Staphylococcus Aureus (MRSA). You can view a list of Dr. David Calfee's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Methicillin-Resistant Staphylococcus Aureus (MRSA)
- Experienced
- PneumoniaDr. Calfee isExperienced. Learn about Pneumonia.
- SepsisDr. Calfee isExperienced. Learn about Sepsis.
- Severe Acute Respiratory Syndrome (SARS)
